Skip to main content
SpringerLink
Log in

Erythropoietic and hepatic porphyrias

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Porphyrias are divided into erythropoietic and hepatic manifestations. Erythropoietic porphyrias are characterized by cutaneous symptoms and appear in early childhood. Erythropoietic protoporphyria is complicated by cholestatic liver cirrhosis and progressive hepatic failure in 10% of patients. Acute hepatic porphyrias (δ-aminolaevulinic acid dehydratase deficiency porphyria, acute intermittent porphyria, hereditary coproporphyria and variegate porphyria) are characterized by variable extrahepatic gastrointestinal, neurological–psychiatric and cardiovascular manifestations requiring early diagnosis to avoid life-threatening complications. Acute hepatic porphyrias are pharmacogenetic and molecular regulatory diseases (without porphyrin accumulation) mainly induced by drugs, sex hormones, fasting or alcohol. The disease process depends on the derepression of hepatic δ-aminolaevulinic acid synthase following haem depletion. In contrast to the acute porphyrias, nonacute, chronic hepatic porphyrias such as porphyria cutanea tarda are porphyrin accumulation disorders leading to cutaneous symptoms associated with liver disease, especially caused by alcohol or viral hepatitis. Alcohol, oestrogens, haemodialysis, hepatitis C and AIDS are triggering factors. Porphyria cutanea tarda is the most common porphyria, followed by acute intermittent porphyria and erythropoietic protoporphyria. The molecular genetics of the porphyrias is very heterogenous. Nearly every family has its own mutation. The mutations identified account for the corresponding enzymatic deficiencies, which may remain clinically silent throughout life. Thus, the recognition of the overt disorder with extrahepatic manifestations depends on the demonstration of biochemical abnormalities due to these primary defects and compensatory hepatic overexpression of hepatic δ-aminolaevulinic acid synthase in the acute porphyrias. Consequently, haem precursors are synthesized in excess. The increased metabolites upstream of the enzymatic defect are excreted into urine and faeces. The diagnosis is based on their evaluation. Primary enzymatic or molecular analyses are noncontributary and may be misleading. Acute polysymptomatic exacerbations accompany a high excretory constellation of porphyrin precursors δ-aminolaevulinic acid and porphobilinogen. Homozygous or compound heterozygous variants of acute hepatic porphyrias may already manifest in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Anderson KE (1989) LHRH analogues for hormonal manipulation in acute intermittent porphyria. Semin Hepatol 26: 10–15.

    Google Scholar 

  • Anderson KE, Spitz IM, Bardin CW, Kappas A (1990) A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Arch Intern Med 150: 1469–1474.

    Google Scholar 

  • Bjersing L, Andersson C, Lithner F (1996) Hepatocellular carcinoma in patients from northern Sweden with AIP: morphology and mutations. Cancer Epidemiol Biomark Prevent 5: 393–397.

    Google Scholar 

  • Blake D, McManus J, Cronin V, Ratnaike S (1992) Fecal coproporphyrin isomers in hereditarycoproporphyria. Clin Chem 38: 96–100

    Google Scholar 

  • Bloomer JR (1988). The liver in protoporphyria. Hepatology 8: 402–407.

    Google Scholar 

  • Bloomer JR, Weimer IC, Bossenmaier IC, Snover DC, Payne WD, Ascher NL (1989) Liver transplantation in a patient with protoporphyria. Gastroenterology 97: 188–194.

    Google Scholar 

  • Bloomer JR, Rank JM, Payne WD, et al (1996) Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg 2: 269–275.

    Google Scholar 

  • Blum M, Koehl C, Abecassis J (1978) Variations in erythrocyte uroporphyrinogen I synthetase activity in non porphyrias. Clin Chim Acta 87: 119–125.

    Google Scholar 

  • Bonkowsky HL, Schady W (1982) Neurologic manifestations of acute porphyria. Semin Liver Dis 2: 108–124.

    Google Scholar 

  • Chretien S, Dubart A, Beaupain D, et al (1988) Alternative transcription and splicing of the human PBG deaminase gene result either in tissue specific or in housekeeping expression. Proc Natl Acad Sci USA 85: 6–10.

    Google Scholar 

  • Dabrowska E, Jablonska-Kaszewska I, Falkiewicz B (1998) High prevalence of hepatitis C virus infection in patients with porphyria cutanea tarda in Poland. Clin Exp Dermatol 23: 95–96.

    Google Scholar 

  • de Castro M, Sanchez J, Herrera JF et al (1993) Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 17: 551–557.

    Google Scholar 

  • Demasi M, Penatti CAA, deLucia R, Bechara EJH (1996) The prooxidant effect of d-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Radic Biol Med 20: 2919.

    Google Scholar 

  • de Torres I, Demetris AJ, Randhawa PS (1996) Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 61: 1412–1433.

    Google Scholar 

  • de Verneuil H, Bourgeois F, de Rooij F, et al (1992) Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria. Hum Genet 89: 548–552.

    Google Scholar 

  • Deybach JC, DaSilva V, Pasquier Y, Nordmann Y (1986) Ferrochelatase in human erythropoietic protoporphyria: the first case of a homozygous form of the enzyme deficiency. In </del>Nordmann Y, ed. Porphyrins and Porphyrias. Colloque INSERM/John Libbey Eurotext, 134, 163–173.

  • Doss M (1978) Relationships between acute hepatic porphyrias due to genetic variability of primary enzyme defects and limiting function of uroporphyrinogen synthase. Int J Biochem 9: 911–916.

    Google Scholar 

  • Doss MO (1987) Porphyrinurias and occupational disease. Ann NY Acad Sci 514: 204–218.

    Google Scholar 

  • Doss MO, Frank M (1989) Hepatobiliary implications and complications in protoporphyria. A 20-year study. Clin Biochem 22: 223–229.

    Google Scholar 

  • Doss MO, Sassa S (1994) The porphyrias. In Noe DA, Rock RC, eds. LaboratoryMedicine. The Selection and Interpretation of Clinical Laboratory Studies. Baltimore, MD: Williams and Wilkins, 535–553, 902–903.

    Google Scholar 

  • Doss M, v. Tiepermann R, Schneider J, Schmid H (1979) New type of hepatic porphyria and porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr 57: 1123–1127.

    Google Scholar 

  • Doss M, Becker U, Peter HJ, Kaffarnik H (1981) Drug safety in porphyria: risks of valproate and metoclopramide. Lancet 2: 91.

    Google Scholar 

  • Doss M, Benkmann HG, Goedde HW (1986) δ-Aminolevulinic acid dehydratase (porphobilinogen synthase) in two families with inherited enzyme deficiency. Clin Gen 30: 191–198.

    Google Scholar 

  • Doss MO, Frank M, Braun-Falco O (1991) Porphyria cutanea tarda: erythrocyte decarboxylase activity in 471 consecutive patients. Curr Prob Dermatol 20: 97–105.

    Google Scholar 

  • Doss MO, GroÞ U, Lamoril J, et al(1999) Compound heterozygous hereditary coproporphyria with fluorescing teeth. Ann Clin Biochem 36: 680–682.

    Google Scholar 

  • Doss MO, Honcamp M, Doss M (2000) Arzneistoffe bei akuten hepatischen Porphyrien und Empfehlungen zur AnÌsthesie. In Rote Liste 2000. Aulendorf/WÏrtt: Editio Cantor, 65–66.

    Google Scholar 

  • Eales L (1980) Liver involvement in erythropoietic protoporphyria. Int J Biochem 12: 915–923.

    Google Scholar 

  • Elder GH (1986) Metabolic abnormalities in the porphyrias. Semin Dermatol 5: 88–98.

    Google Scholar 

  • Elder GH (1997) Hepatic porphyrias in children. J Inherit Metab Dis 20: 237–246.

    Google Scholar 

  • Elder GH, Roberts AG (1995) Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 27: 207–213.

    Google Scholar 

  • Elder GH, Hift RJ, Meissner PN (1997) The acute porphyrias. Lancet 349: 1613–1616.

    Google Scholar 

  • Fargion S, Piperno A, Cappellini MD (1992) Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 16: 1322–1326.

    Google Scholar 

  • Ferri C, Baicchi U, LaCivita L, et al (1993) Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 23: 851–855.

    Google Scholar 

  • Frank M, Doss MO (1995) Leberzirrhose bei Protoporphyrie: Gallensäurentherapie und Lebertransplantation. Z Gastroenterol 33: 399–403.

    Google Scholar 

  • Frank J, Wang X, Lam HM, et al (1998) C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Ann Hum Genet 62: 225–230.

    Google Scholar 

  • Freesemann AG, Bhutani LK, Jacob K, Doss MO (1997a) Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease). Arch Dermatol Res 289: 272–276.

    Google Scholar 

  • Freesemann AG, Hofweber K, Doss MO (1997b) Coexistence of deficiencies of uroporphyrinogen III synthase and decarboxylase in a patient with congenital erythropoietic porphyria and in his family. Eur J Clin Chem Clin Biochem 35: 35–39.

    Google Scholar 

  • Freesemann AG, Greil J, Beck JD, Doss MO (1999) Porphyrinstoffwechsel vor und nach allogener Knochenmarkstransplantation bei kongenitaler erythropoetischer Porphyrie. Med Klinik 94: 145.

    Google Scholar 

  • Galbraith RA, Drummond GS, Kappas A (1985) Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications. J Clin Invest 76: 2436–2439.

    Google Scholar 

  • Garey R, Harrison LM, Franklin KF, Metcalf KM, Radisky ES, Kushner JP (1990) Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest 86: 1416–1422.

    Google Scholar 

  • Garey JR, Franklin KF, Brown DA, Harrison LM, Metcalf KM, Kushner JP (1993) Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterol 105: 165–169.

    Google Scholar 

  • Gauer EB, Doss MO, Riemann FJ (1995) Erythrohepatische Protoporphyrie. Eine seltene Differentialdiagnose des parenchymatÎsen Ikterus. Dtsch Med Wschr 120: 713–717.

    Google Scholar 

  • Goetsch CA, Montgomery Bissell D (1986) Instability of hematin used in the treatment of acute hepatic porphyria. N Engl J Med 315: 235–238.

    Google Scholar 

  • Gorchein A (1997) Drug treatment in acute porphyria. Br J Clin Pharmacol 44: 427–434.

    Google Scholar 

  • Gouya L, Puy H, Lamoril J, et al (1999) Inheritance in erythropoietic protoporphyria: a common wild type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 93: 2105–2110.

    Google Scholar 

  • Grandchamp B (1998) Acute intermittent porphyria. In Schmid R, <nt>ed.</nt> The Porphyrias. Semin Liver Dis 18: 17–24.

  • Greene-Davis ST, Neumann PE, Mann OE, et al (1997) Detection of a R173W mutation in the porphobilinogen deaminase gene in the Nova Scotian “foreign protestant” population with acute intermittent porphyria: a founder effect. Clin Biochem 30: 607–612.

    Google Scholar 

  • Groβ U, Honcamp M, Daume E, Frank M, Düsterberg B, Doss MO (1995) Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias. Horm Metab Res 27: 379–383.

    Google Scholar 

  • Groβ U, Honcamp M, Doss MO (1996) Heterogeneity of AIP: a subtype with normal PBG deaminase activity in erythrocytes in Germany. Eur J Clin Chem Clin Biochem 34: 613–618.

    Google Scholar 

  • Groβ U, Frank M, Doss MO (1998a) Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 14: 52–57.

    Google Scholar 

  • GroÞ U, Sassa S, Jacob K, et al (1998b) 5-Aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical follow-up. Clin Chem 44: 1892–1896.

    Google Scholar 

  • Groβ U, Puy H, Doss M, et al (1999) New mutations of the hydroxymethylbilane synthase gene inGerman patients with acute intermittent porphyria. Mol Cell Probes 14: 443–447.

    Google Scholar 

  • Gu XF, de Rooij F, Lee JS, et al (1993) High prevalence of a point mutation in the porphobilinogen deaminase gene in Dutch patients with acute intermittent porphyria. Hum Genet 91: 128–130.

    Google Scholar 

  • Held JL, Sassa S, Kappas A, Harber LC (1989) Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J Invest Dermatol 93: 332–334.

    Google Scholar 

  • Henriksson M, Timonen K, Mustajoki P (1996) Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. J Invest Dermatol 106: 346–350.

    Google Scholar 

  • Hindmarsh JT (1993) Variable phenotypic expression of genotypic abnormalities in the porphyrias. Clin Chim Acta 217: 29–38.

    Google Scholar 

  • Ishida N, Fujita H, Fukuda Y, et al (1992) Cloning and expression of the defective genes from a patient with δ-aminolevulinate dehydratase porphyria. J Clin Invest 89: 1431–1437.

    Google Scholar 

  • Jenkins MM, LeBoef RD, Ruth GR, Bloomer JR (1998) A novel stop codon mutation (X417L) of the ferrochelatase gene in bovine protoporphyria, a natural animal model of the human disease. Biochim Biophys Acta 1408: 18–24.

    Google Scholar 

  • Jensen JD, Resnick SD (1995) Porphyria in childhood. Semin Dermatol 14: 33–39.

    Google Scholar 

  • Johnson JA, Fusaro RM (1989) Prognosis of liver transplantation in patients with erythropoietic protoporphyria. Transplantation 48: 175–176.

    Google Scholar 

  • Kappas A, Sassa S, Galbraith RA, Nordmann Y (1995) The porphyrias. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2103–2151.

    Google Scholar 

  • Kauppinen R, Mustajoki P (1992) Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated disease. Medicine 71: 1–13.

    Google Scholar 

  • Kauppinen R, Timonen K, Mustajoki P (1994) Treatment of the porphyrias. Ann Med 26: 31–38.

    Google Scholar 

  • Kauppinen R, Glass IA, Aizencang G, Astrin KH, Atweh GF, Desnick RJ (1998) Congenital erythropoietic porphyria: prolonged high-level expression and correction of the haem biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells. Mol Gen Metab 65: 10–17.

    Google Scholar 

  • Klimpel D, Dittrich J, v. Tiepermann R, Doss M(1978) Acute intermittent porphyria and cerebral attacks in childhood. J Clin Chem Clin Biochem 16: 45–46.

    Google Scholar 

  • Kühnel A, Groβ U, Jacob K, Doss MO (1999) Studies on coproporphyrin isomers in urine and feces in the porphyrias. Clin Chim Acta 282: 45–58.

    Google Scholar 

  • Lacour JPH, Bodokh I, Castanet J, Bekri S, Ortonne JP (1993) Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 128: 121–123.

    Google Scholar 

  • Lamoril J, Boulechfar S, Verneuil Hde, Grandchamp B, Nordmann Y, Deybach J-C (1991) Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun 181: 594–599.

    Google Scholar 

  • Lee JS, Anvret M (1991) Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria. Proc Natl Acad Sci USA 88: 10912–10915.

    Google Scholar 

  • Litman DA, Correia MA (1983) L-Tryptophan a common denominator of biochemical and neurological events of acute porphyrias? Science 22: 1031–1033.

    Google Scholar 

  • Lock G, Holstege A, Mueller AR, et al(1996) Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy. Liver 16: 211–217.

    Google Scholar 

  • Martäsek P (1998) Hereditary coproporphyria. Semin Liver Dis 18: 25–32.

    Google Scholar 

  • Mascaro JM (1992) Porphyrias in children. Pediatr Dermatol 9: 371–372.

    Google Scholar 

  • Mazurier F, Moreau-Gaudry F, Salesse S, et al (1997) Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inherit Metab Dis 20: 247–257.

    Google Scholar 

  • Meissner P, Adams P, Kirsch R (1993) Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. J Clin Invest 91: 1436–1444.

    Google Scholar 

  • Mendez M, Sorkin L, Rossetti MV, et al (1998) Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet 63: 1363–1375.

    Google Scholar 

  • Mercurio MG, Prince G, Weber FL Jr, Jacobs G, Zaim MT, Bickers DR (1993) Terminal hepatic failure in erythropoietic protoporphyria. J Am Acad Dermatol 29: 829–833.

    Google Scholar 

  • Moore MR (1980) International review of drugs in acute porphyriaö1980. Int J Biochem 12: 1089–1097.

    Google Scholar 

  • Moore M (1993) Biochemistry of porphyria. Int J Biochem 25: 1353–1368.

    Google Scholar 

  • Moran-Jimenez MJ, Ged C, Romana M, et al (1996) Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet 58: 712–721.

    Google Scholar 

  • Mustajoki P (1985) Prevention and treatment of acute porphyric attacks. Ann Clin Res 17: 289–291.

    Google Scholar 

  • Mustajoki P, Nordmann Y (1993) Early administration of haem arginate for acute porphyric attacks. Arch Intern Med 153: 2004–2008.

    Google Scholar 

  • Mustajoki P, Kauppinen R, Lannfelt L, Koistinen J (1992) Frequency of low PBG deaminase activity in Finland. J Intern Med 231: 389–395.

    Google Scholar 

  • Mustajoki S, Kauppinen R, Mustajoki P, Suomalainen A, Peltonen L (1997) Steady-state transcript levels of the porphobilinogen deaminase gene in patients with acute intermittent porphyria. Genome Res 7: 1054–1060.

    Google Scholar 

  • Mustajoki S, Pihlaja H, Ahola H, Peterson NE, Mustajoki P, Kauppinen R (1998) Three splicing defects, an insertion, and two missense mutations responding for acute intermittent porphyria. Hum Genet 102: 541–548.

    Google Scholar 

  • Nordmann Y (1992) Erythropoietic protoporphyria and hepatic complications. Hepatology 16: 4–6.

    Google Scholar 

  • Petersen NE, Nissen H, Hørder M, Senz J, Jamani A, Schreiber WE (1998) Mutation screening by denaturing gradient gel electrophoresis in North American patients with acute intermittent porphyria. Clin Chem 44: 1766–1768.

    Google Scholar 

  • Poh-Fitzpatrick MB (1994) Erythropoietic protoporphyria. Semin Dermatol 5: 99–105.

    Google Scholar 

  • Poh-Fitzpatrick MB (1998) Clinical features of the porphyrias. Clin Dermatol 16: 251–264.

    Google Scholar 

  • Polson RJ, Lim CK, Rolles K, Calne Y, Williams R (1988) The effect of liver transplantation in a 13 year old boy with erythropoietic protoporphyria. Transplantation 46: 386–389.

    Google Scholar 

  • Puy H, GroÞ U, Deybach JCh, et al (1998) Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria. Hum Genet 103: 570–575.

    Google Scholar 

  • Rank JM, Carithers R, Bloomer J (1993) Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology 18: 1404–1409.

    Google Scholar 

  • Robert TL, Varella L, Meguid MM (1994) Nutrition management of acute intermittent porphyria. Nutrition 10: 551–555.

    Google Scholar 

  • Rüfenacht UB, Gouya L, Schneider-Yin X, et al (1998) Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62: 1341–1352.

    Google Scholar 

  • Salmon P, Oakley A, Rademaker M, Duffill M (1996) Hepatitis C virus infection and porphyria cutanea tarda in Australia. Arch Dermatol 132: 91.

    Google Scholar 

  • Samuel D, Boboc B, Bernuau J, Bismuth H, Benhamou JP (1988) Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin over-production. Gastroenterology 95: 816–819.

    Google Scholar 

  • Sarkany RPE, Cox TM (1995) Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure. Q J Med 88: 541–549.

    Google Scholar 

  • Sarkany RPE, Alexander GJMA, Cox TM(1994) Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 343: 1394–1396.

    Google Scholar 

  • Sassa S (1996) Diagnosis and therapy of acute intermittent porphyria. Blood Rev 10: 53–58.

    Google Scholar 

  • Sassa S (1998) ALAD porphyria. Semin Liver Dis 18: 95–101.

    Google Scholar 

  • Schneider-Yin X, Schäfer BW, Tönz O, Minder EI (1995) Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing. Hum Genet 95: 391–396.

    Google Scholar 

  • Sieg I, Rohrbacher C, Bavastro P, Doss MO (1992) Kumulative Manifestationsfaktoren bei akuter intermittierender Porphyrie. Med Klin 87: 318–322.

    Google Scholar 

  • Sixel-Dietrich F, Doss M (1985) Hereditary uroporphyrinogen decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res 278: 13–16.

    Google Scholar 

  • Steinmüller T, Doss MO, Steffen R, et al (1992) Lebertransplantation bei erythrohepatischer Protoporphyrie. Dtsch Med Wschr 117: 1097–1102.

    Google Scholar 

  • Stölzel U, Doss MO, Dissmann T, Cervós-Navarro J, Riecken EO (1987) Gastroenterologische und neurologische Manifestation bei akuter intermittierender Porphyrie. Med Klin 82: 520–525.

    Google Scholar 

  • Stölzel U, Köstler E, Koszka C, et al (1995) Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21: 1500–1503.

    Google Scholar 

  • Thomas C, Ged C, Nordmann Y, et al (1996) Correction of congenital erythropoietic porphyria by bone marrow transplantation. J Pediatr 129: 453–456.

    Google Scholar 

  • Thunell S, Anderson C, Carlmark B, et al (1995) Markers for vulnerability in acute porphyria. A hypothesis paper. Eur J Clin Chem Clin Biochem 33: 179–194.

    Google Scholar 

  • Todd DJ (1994) Erythropoietic protoporphyria. Br J Dermatol 131: 751–766.

    Google Scholar 

  • Todd DJ (1998) Molecular genetics of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed 14: 70–73.

    Google Scholar 

  • Wagner S, Doss MO, Wittekind C, BÌcker U, Meesen D, Schmidt FW (1989) Erythrohepatische Protoporphyrie mit rasch progredienter Leberzirrhose. Dtsch Med Wschr 114: 1837–1841.

    Google Scholar 

  • Wang H, Long Q, Marty SD, Sassa S, Lin S (1998) A zebra¢sh model for hepatoerythropoietic porphyria. Nature Genetics 20: 239–243.

    Google Scholar 

  • Zix-Kieffer I, Langer B, Eyer D, et al (1996) Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease). Bone Marrow Transplant 18: 217–220.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Biochemistry, Faculty of Medicine, Philipps University, Marburg

    U. Gross

  2. Department of General Pediatrics, University Children's Hospital, Heidelberg, Germany

    G. F. Hoffmann

  3. Division of Clinical Biochemistry, Faculty of Medicine, Philipps University, Marburg

    M. O. Doss

Authors
  1. U. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. F. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. O. Doss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gross, U., Hoffmann, G.F. & Doss, M.O. Erythropoietic and hepatic porphyrias. J Inherit Metab Dis 23, 641–661 (2000). https://doi.org/10.1023/A:1005645624262

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005645624262

Keywords

Search

Navigation